B. Pötzsch

G. Müller‐Berghaus, B. Pötzsch, G. Klaus, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers but not of Prothrombin 20210G>A Carriers.

J. Oldenburg, Jens Müller, B. Pötzsch, 2019, Circulation research.

V. Hach-Wunderle, G. Müller‐Berghaus, G. Salzmann, 1997, American journal of surgery.

Haemostasis management of massive bleeding

V. Ivaškevičius, B. Pötzsch, 2011, Hämostaseologie.

Assay for ADAMTS-13 Activity with Flow Cytometric Readout

Jens Müller, J. Oldenburg, N. S. Hamedani, 2022, ACS omega.

Absence of fibrinogen α‐, β‐ and γ‐chain mRNA in human platelets

Jens Müller, B. Pötzsch, J. Rox, 2005, British journal of haematology.

Recombinant hirudin is a heparin alternative in cardiac surgery.

A. Greinacher, G. Müller‐Berghaus, N. Bleese, 1997, Journal of cardiothoracic and vascular anesthesia.

A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery.

A. Greinacher, G. Müller‐Berghaus, N. Bleese, 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

U. Janssens, A. Greinacher, H. Kwasny, 1999, Circulation.

Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.

G. Müller‐Berghaus, N. Bleese, F. Riess, 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach.

J. Oldenburg, G. Mayer, Jens Müller, 2016, Nucleic acid therapeutics.

Extended Half-Life Factor VIII/Factor IX Products: Assay Discrepancies and Implications for Hemophilia Management

J. Oldenburg, Jens Müller, B. Pötzsch, 2020, Hämostaseologie.

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.

U. Janssens, A. Greinacher, V. Hach-Wunderle, 1999, Circulation.

[New insight in therapeutic anticoagulation by Coumarin derivatives].

J. Oldenburg, M. Watzka, B. Pötzsch, 2008, Hamostaseologie.

Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture

W. Schaper, J. Schaper, D. Scholz, 1996, Cell and Tissue Research.

Chemical Maturation of a Bivalent Aptamer by Single Domain Variation

G. Mayer, Jens Müller, E. Pedersen, 2012, Chembiochem : a European journal of chemical biology.

Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24

Bernhard Horsthemke, Jan Freudenberg, Elisabeth Mangold, 2009, Nature Genetics.

Glycophorin A-based exclusion of red blood cells for flow cytometric analysis of platelet glycoprotein expression in citrated whole blood

J. Oldenburg, Jens Müller, B. Pötzsch, 2020, Clinical chemistry and laboratory medicine.

Gene expression analysis in platelets from a single donor: evaluation of a PCR-based amplification technique.

P. Bugert, Jens Müller, P. Hanfland, 2004, Clinical chemistry.

Aptamer loaded superparamagnetic beads for selective capturing and gentle release of activated protein C

G. Mayer, E. Klein, J. Oldenburg, 2022, Scientific reports.

Platelet Transcriptome Analysis*

Jens Müller, B. Pötzsch, J. Rox, 2006, Transfusion Medicine and Hemotherapy.

Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin.

W. Seeger, F. Grimminger, N. Suttorp, 1997, Journal of immunology.

Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.

J. Oldenburg, S. Held, A. Heine, 2016, Cytotherapy.

Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.

K. Preissner, G. Müller‐Berghaus, B. Pötzsch, 1995, The Journal of laboratory and clinical medicine.

The Use of Heparinase Improves the Specificity of Crossreactivity Testing in Heparin-induced Thrombocytopenia

B. Pötzsch, K. Madlener, Martin Keller, 1996, Thrombosis and Haemostasis.

Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand-Factor

J. White, A. Greinacher, G. Müller‐Berghaus, 1993, Annals of Hematology.

Chorea and antiphospholipid antibodies: Treatment with methotrexate

T. Klockgether, S. Paus, U. Wüllner, 2001, Neurology.

In vivo thrombin generation and subsequent APC formation are increased in factor V Leiden carriers.

J. Oldenburg, Jens Müller, B. Pötzsch, 2018, Blood.

Investigation of dominant and recessive inheritance models in genome-wide association studies data of nonsyndromic cleft lip with or without cleft palate.

M. Nöthen, M. Knapp, T. Kreusch, 2018, Birth defects research.

Resequencing of VAX1 in patients with nonsyndromic cleft lip with or without cleft palate.

M. Nöthen, C. Lange, Philipp Wahle, 2012, Birth defects research. Part A, Clinical and molecular teratology.

TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia.

J. Oldenburg, G. Nickenig, J. Sinning, 2016, International journal of cardiology.

PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison

A. Tiede, Jens Müller, U. Sachs, 2021, Thrombosis and Haemostasis.

Polymorphisms in VKORC1 and GGCX are not major genetic determinants of vitamin K-dependent coagulation factor activity in Western Germans

J. Oldenburg, M. Watzka, B. Pötzsch, 2009, Thrombosis and Haemostasis.

The evolution of activated protein C plasma levels in septic shock and its association with mortality: A prospective observational study☆

M. Borggrefe, I. Akin, T. Becher, 2018, Journal of critical care.

Plasmatic coagulation profile after major traumatic injury: a prospective observational study

B. Bouillon, M. Maegele, N. Schäfer, 2022, European Journal of Trauma and Emergency Surgery.

Ex Vivo Modeling of the PC (Protein C) Pathway Using Endothelial Cells and Plasma: A Personalized Approach

H. Yadegari, J. Oldenburg, N. S. Hamedani, 2022, Arteriosclerosis, thrombosis, and vascular biology.

Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants

J. Oldenburg, Jens Müller, B. Pötzsch, 2020, Scientific Reports.

Short-term venous stasis induces fibrinolytic activation but not thrombin formation.

J. Oldenburg, O. Dewald, Jens Müller, 2014, Journal of atherosclerosis and thrombosis.

Anticoagulant characteristics of HD1‐22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase

Jens Müller, J. MÜLLER, D. FREITAG, 2008, Journal of thrombosis and haemostasis : JTH.

▼Zoely: a new combined oral contraceptive

L. Mullany, J. Oldenburg, W. Kuhn, 2014, Drug and Therapeutics Bulletin.

Platelet-Dependent Thrombin Generation Induced By ADP or Activated Factor X Does Not Contribute to Increased In Vivo Thrombin Formation in Myeloproliferative Neoplasms

J. Oldenburg, P. Brossart, D. Wolf, 2018, Blood.

Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.

A. Biswas, J. Oldenburg, Kornelia Hardes, 2019, Journal of medicinal chemistry.

Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency

A. Heckel, G. Mayer, Jens Müller, 2009, Nucleic acids research.

Application of the TaqMan-PCR for Genotyping of the Prothrombi G20210A Mutation and of the Thermolabile Methylenetetrahydrofolate Reductase Mutation

R. Schwaab, P. Hanfland, B. Pötzsch, 2000, Thrombosis and Haemostasis.

Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation

J. Oldenburg, Jens Müller, B. Pötzsch, 2020, Journal of atherosclerosis and thrombosis.

Characterization of circulating thrombin in patients with septic shock: a prospective observational study

M. Borggrefe, I. Akin, T. Becher, 2019, Journal of Thrombosis and Thrombolysis.

Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson’s Disease

H. Fröhlich, F. Lang, Amit Sharma, 2021, Biology.

Comprehensive Proﬁling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson’s Disease

H. Fröhlich, F. Lang, J. Oldenburg, 2021 .

Differential Regulation of Protein Subdomain Activity with Caged Bivalent Ligands

A. Heckel, G. Mayer, Jens Müller, 2009, Chembiochem : a European journal of chemical biology.

PCR-Based amplification of platelet mRNA sequences obtained from small-scale platelet samples.

Jens Müller, B. Pötzsch, J. Rox, 2009, Methods in molecular biology.

Thrombophilia in a Child with CDG-Syndrome Type I

W. Kreuz, M. Funk, B. Pötzsch, 1995, Thrombosis and Haemostasis.

Nonsyndromic cleft lip with or without cleft palate: Increased burden of rare variants within Gremlin-1, a component of the bone morphogenetic protein 4 pathway.

M. Nöthen, C. Lange, P. Hoffmann, 2014, Birth defects research. Part A, Clinical and molecular teratology.

In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile

J. Oldenburg, A. Pavlova, J. Driesen, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation

J. Oldenburg, V. Ivaškevičius, B. Pötzsch, 2016, Thrombosis and Haemostasis.

Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose

J. Ferro, J. K. Kremer Hovinga, G. Frisullo, 2022, Blood.

Anticoagulant characteristics of HD1‐22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase

Jens Müller, B. Pötzsch, D. Freitag, 2008, Journal of Thrombosis and Haemostasis.

Aptamer-Based Enzyme Capture Assay for Measurement of Plasma Thrombin Levels.

G. Mayer, Jens Müller, B. Pötzsch, 2016, Methods in molecular biology.

Multidomain Targeting Generates a High‐Affinity Thrombin‐Inhibiting Bivalent Aptamer

G. Mayer, Jens Müller, B. Pötzsch, 2007, Chembiochem : a European journal of chemical biology.

Resolution of giant left atrial appendage thrombus with rivaroxaban

G. Nickenig, C. Hammerstingl, B. Pötzsch, 2013, Thrombosis and Haemostasis.

Resequencing of VAX1 in patients with nonsyndromic cleft lip with or without cleft palate.

M. Nöthen, C. Lange, Philipp Wahle, 2012, Birth defects research. Part A, Clinical and molecular teratology.

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.

J. Brachmann, M. Schindewolf, P. Dohmen, 2014, Thrombosis research.

Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A

J. Oldenburg, M. Spannagl, Jens Müller, 2019, Thrombosis and Haemostasis.

Molecular insights and functional consequences of the interaction of heme with activated protein C.

A. Biswas, J. Oldenburg, D. Imhof, 2020, Antioxidants & redox signaling.

[The management of patients with heparin-induced thrombocytopenia].

B. Pötzsch, K. Madlener, 2006, Hamostaseologie.